Zobrazeno 1 - 10
of 742
pro vyhledávání: '"Chemotherapy induced neutropenia"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Breast cancer remains a significant public health issue, often resulting in severe side effects such as neutropenia, highlighting the need for reliable predictors of clinical outcomes. This study aimed to evaluate the predictive value of bod
Externí odkaz:
https://doaj.org/article/ba9af72e10d943198576ac4324b580f1
Autor:
Yantao Jiang, Ju Zhang, Jianxin Zhong, Hao Liao, Jiayang Zhang, Yaxin Liu, Yuehua Liang, Huiping Li
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background To compare the clinical value of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and pegylated rhG-CSF(PEG-rhG-CSF) in early-stage breast cancer (EBC) patients receiving adjuvant chemotherapy, compare the efficac
Externí odkaz:
https://doaj.org/article/dc1b094791d24b908fbb97336af9984e
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 73, Iss 6 (2023)
Objectives: To determine the frequency of bacterial infections and their sensitivity to various antibiotics in paediatric cancer patients having chemotherapy-induced neutropenia. Study Design: Cross-sectional study Place and Duration of Study: Pa
Externí odkaz:
https://doaj.org/article/dad0000ac3964fdfadaf5cc18c2f3799
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Africa Nursing Sciences, Vol 19, Iss , Pp 100604- (2023)
Background: Neutropenia is one of the most common risk factors for infections in patients with poor immune competency. Objective: To determine nurses’ knowledge and care practices for infection prevention in chemotherapy-induced neutropenic patient
Externí odkaz:
https://doaj.org/article/633df1a09e4d45a3a5f941713b765435
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Piera Gargiulo, Laura Arenare, Cesare Gridelli, Alessandro Morabito, Fortunato Ciardiello, Vittorio Gebbia, Paolo Maione, Alessia Spagnuolo, Giuliano Palumbo, Giovanna Esposito, Carminia Maria Della Corte, Floriana Morgillo, Gianfranco Mancuso, Raimondo Di Liello, Adriano Gravina, Clorinda Schettino, Massimo Di Maio, Ciro Gallo, Francesco Perrone, Maria Carmela Piccirillo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Chemotherapy-induced neutropenia (CIN) has been demonstrated to be a prognostic factor in several cancer conditions. We previously found a significant prognostic value of CIN on overall survival (OS), in a pooled dataset of patien
Externí odkaz:
https://doaj.org/article/a4ff3976bddf475882f1ba7ca7d1a374
Autor:
Yi Ba, Yuankai Shi, Wenqi Jiang, Jifeng Feng, Ying Cheng, Li Xiao, Qingyuan Zhang, Wensheng Qiu, Binghe Xu, Ruihua Xu, Bo Shen, Zhiguo Luo, Xiaodong Xie, Jianhua Chang, Mengzhao Wang, Yufu Li, Yuerong Shuang, Zuoxing Niu, Bo Liu, Jun Zhang, Li Zhang, Herui Yao, Conghua Xie, Huiqiang Huang, Wangjun Liao, Gongyan Chen, Xiaotian Zhang, Hanxiang An, Yanhong Deng, Ping Gong, Jianping Xiong, Qinghua Yao, Xin An, Cheng Chen, Yanxia Shi, Jialei Wang, Xiaohua Wang, Zhiqiang Wang, Puyuan Xing, Sheng Yang, Chenfei Zhou
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 4, Pp 896-909 (2020)
Chemotherapy-induced neutropenia (CIN) is a potentially fatal and common complication in myelosuppressive chemotherapy. The timing and grade of CIN may play prognostic and predictive roles in cancer therapy. CIN is associated with older age, poor fun
Externí odkaz:
https://doaj.org/article/f72ffabad7544f8893db0dea38924e2d
Autor:
Patrick Wayne Cobb, Yong Wha Moon, Klára Mezei, István Láng, Gajanan Bhat, Shanta Chawla, Steven J. Hasal, Lee S. Schwartzberg
Publikováno v:
Cancer Medicine, Vol 9, Iss 17, Pp 6234-6243 (2020)
Abstract Eflapegrastim (Rolontis®) is a novel, long‐acting hematopoietic growth factor consisting of a recombinant human granulocyte‐colony stimulating factor (rhG‐CSF) analog conjugated to a human IgG4 Fc fragment via a short polyethylene gly
Externí odkaz:
https://doaj.org/article/88a9560255c6486fb96283aa83575700